Cargando…
Efficacies of DHA–PPQ and AS/SP in patients with uncomplicated Plasmodium falciparum malaria in an area of an unstable seasonal transmission in Sudan
BACKGROUND: Artemisinin-based combination therapy (ACT), together with other control measures, have reduced the burden of falciparum malaria in sub-Saharan countries, including Sudan. Sudan adopted ACT in 2004 with a remarkable reduction in mortality due to falciparum malaria. However, emergence of...
Autores principales: | Mohamed, Abdelrahim O., Abdel Hamid, Muzamil M., Mohamed, Omer S., Elkando, Nuha S., Suliman, Abdelmaroof, Adam, Mariam A., Elnour, Fahad Awad Ali, Malik, Elfatih M. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2017
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5399425/ https://www.ncbi.nlm.nih.gov/pubmed/28427409 http://dx.doi.org/10.1186/s12936-017-1817-9 |
Ejemplares similares
-
Assessment of Plasmodium falciparum drug resistance molecular markers from the Blue Nile State, Southeast Sudan
por: Mohamed, Abdelrahim O., et al.
Publicado: (2020) -
Artesunate plus sulfadoxine-pyrimethamine for treatment of uncomplicated Plasmodium falciparum malaria in Sudan
por: Elamin, Sakina B, et al.
Publicado: (2005) -
Multiplicity of infection and genetic diversity of Plasmodium falciparum isolates from patients with uncomplicated and severe malaria in Gezira State, Sudan
por: Mahdi Abdel Hamid, Muzamil, et al.
Publicado: (2016) -
Pharmacokinetics of Piperaquine in Pregnant Women in Sudan with Uncomplicated Plasmodium falciparum Malaria
por: Adam, Ishag, et al.
Publicado: (2012) -
Antimalarial drug resistance molecular makers of Plasmodium falciparum isolates from Sudan during 2015–2017
por: Hussien, Maazza, et al.
Publicado: (2020)